really really good, page-4

Megan Baldwin certainly is an impressive interviewee. A few interesting comments interwoven into these interviews. When talking about the phase 1 results "great and as good as could expect". The fact that a few letters or a line improvement on an eye chart can mean the difference between being able to drive or read. Planning for 2b trial starting mid 2017 and the possibility 2a results could be out slightly earlier than the end of March 2017. Encouraging results is the phrase that comes up in these interviews a lot and as an investor I too am feeling encouraged.